全文获取类型
收费全文 | 9735篇 |
免费 | 1064篇 |
国内免费 | 274篇 |
专业分类
耳鼻咽喉 | 9篇 |
儿科学 | 430篇 |
妇产科学 | 50篇 |
基础医学 | 658篇 |
口腔科学 | 43篇 |
临床医学 | 1302篇 |
内科学 | 1005篇 |
皮肤病学 | 203篇 |
神经病学 | 142篇 |
特种医学 | 378篇 |
外科学 | 1710篇 |
综合类 | 1610篇 |
现状与发展 | 1篇 |
预防医学 | 1096篇 |
眼科学 | 60篇 |
药学 | 761篇 |
7篇 | |
中国医学 | 1525篇 |
肿瘤学 | 83篇 |
出版年
2024年 | 61篇 |
2023年 | 284篇 |
2022年 | 579篇 |
2021年 | 603篇 |
2020年 | 579篇 |
2019年 | 388篇 |
2018年 | 390篇 |
2017年 | 493篇 |
2016年 | 467篇 |
2015年 | 449篇 |
2014年 | 865篇 |
2013年 | 810篇 |
2012年 | 772篇 |
2011年 | 817篇 |
2010年 | 611篇 |
2009年 | 429篇 |
2008年 | 348篇 |
2007年 | 340篇 |
2006年 | 268篇 |
2005年 | 222篇 |
2004年 | 171篇 |
2003年 | 137篇 |
2002年 | 99篇 |
2001年 | 108篇 |
2000年 | 94篇 |
1999年 | 79篇 |
1998年 | 69篇 |
1997年 | 56篇 |
1996年 | 68篇 |
1995年 | 46篇 |
1994年 | 50篇 |
1993年 | 43篇 |
1992年 | 37篇 |
1991年 | 11篇 |
1990年 | 26篇 |
1989年 | 21篇 |
1988年 | 33篇 |
1987年 | 18篇 |
1986年 | 16篇 |
1985年 | 15篇 |
1984年 | 17篇 |
1983年 | 14篇 |
1982年 | 17篇 |
1981年 | 14篇 |
1980年 | 10篇 |
1979年 | 3篇 |
1978年 | 5篇 |
1976年 | 7篇 |
1975年 | 5篇 |
1974年 | 3篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
BackgroundPassive and hybrid passive ankle foot orthoses (AFOs) are often prescribed in post stroke drop foot; however, the effects of these AFOs on balance related parameters in these patients seem unclear. Accordingly, the aim of current study was to evaluate the role of the newly designed hybrid passive and Posterior Leaf Spring (PLS) AFOs on balance related parameters including: self-reported balance confidence (ABC), Timed Up and Go Test (TUG) and Berg Balance Scale (BBS) in post stroke drop foot patients.MethodsFifteen post stroke drop foot patients were recruited in current study. Then, ABC, TUG and BBS were assessed with newly designed AFO and PLS AFO.ResultsThe results of this study were shown a significant improvement in ABC, TUG and BBS scores with the newly designed AFO than PLS AFO (p < 0.05).ConclusionThis study suggested that the newly designed AFO was improved the balance related parameters than PLS AFO. 相似文献
2.
3.
4.
ObjectiveThis study used a prospective cohort study to observe the effect of triple-negative breast cancer on the 2-year disease-free survival rate with or without “TCM formula”.MethodsFrom November 1 st, 2016, the first patient was enrolled in the cohort study. A total of 356 patients were enrolled on January 30, 2019. Among them, 154 cases were followed up for 2 years. During the follow-up, there were 6 cases of shedding, so 6 cases were affected. A total of 148 cases were included in the analysis, including 73 in the exposed group and 75 in the non-exposed group. The exposed group was given “TCM formula” on the basis of standardized treatment, and the non-exposed group was treated with simple triple-negative breast cancer. The two groups visited each of the three months. The interview included safety examination (hematology and imaging). The endpoint was the difference in 2-year invasive disease-free survival between the exposed and non-exposed groups and the safety of the “TCM formula”.ResultsThere were 6 cases of shedding during the experiment and the shedding rate was 3.9 %. The 2-year rate of invasive disease-free survival in the exposed team was 88.7 % and the non-exposed group was 82.5 %. Logistic multivariate regression analysis predicted that “TCM formula” could reduce the disease-related recurrence and metastasis rate by 11 % (OR = 0.89, 95 % CI 0.37−0.956, P<0.05). Through K–M survival analysis, TNBC patients with age ≤35 years and regional lymph node stage N1 may be the benefit group of “TCM formula”(P<0.05). During the study, the incidence of total adverse events was 8.2 % in the exposed group, mainly manifested as stomach discomfort, diarrhea, and hepatocyte damage.Conclusion1. In the exposed group, the two-year rate of invasive disease-free survival increased by 6.2 % compared with the non-exposed group(P>0.05). 2. According to K–M survival analysis, TNBC patients with age ≤35 years and regional lymph node metastasis to N1 may be potential beneficiaries of “TCM formula”. 3. “TCM Formula” is safe and tolerable to most patients. 相似文献
5.
6.
7.
8.
9.
中药复方是由2味或2味以上中药遵循中医理论组合而成的方剂。多味中药在合适的剂量配比之下,协同发挥作用,实现中医的整体调节治疗。研究中药复方的配伍对推动中药现代化发展、新药开发以及临床应用有着重要意义。近年来,研究者们在传统的"七情和合"与"君臣佐使"的基础上,运用新技术和新方法对中药复方的成分、药效活性和药代动力学性质等进行了研究,从不同角度探讨了中药复方配伍的科学内涵。同时,多种数理方法和模型的建立、网络药理学和数据挖掘方法的发展与应用,也对中药复方配伍研究提供了很大帮助。研究方法的发展虽促进了中药复方配伍的科学研究,但还需进一步建立适合中药复方配伍复杂关系的研究方法,以阐明中药复方及其成分/组分配伍的内在规律,进而构建新的现代中药复方,这也是目前中药复方配伍研究的重点任务。 相似文献
10.
糖尿病足溃疡(DFUs)是糖尿病严重的并发症之一,发病率和截肢率高,目前具体发病机制仍未完全明确。相关研究表明,炎症、感染和营养障碍等多种因素共同影响DFUs的转归及预后。抑制相关炎症通路和细胞因子表达,可促使坏死组织脱落促进愈合。此外,细胞因子信号传导抑制因子家族蛋白(SOCS)可通过激活蛋白酪氨酸激酶(JAK)/信号转导和转录活化因子(STAT)信号通路参与细胞因子信号转导,参与DFUs创面炎症反应以及愈合过程。近年来,大量研究发现具有“去腐生新”功效的单味中药及其活性成分、中药复方对DFUs具有很好的疗效,研究中药治疗DFUs的具体机制已成为近些年来研究的热点之一。文章查阅近年文献,就SOCS通路与DFUs的关系及中医药治疗DFUs作用机制进行综述。 相似文献